Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
6.3M
-
Shares change
-
-980K
-
Total reported value, excl. options
-
$12.7M
-
Value change
-
-$2.02M
-
Put/Call ratio
-
0.26
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$2.02
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2020
31 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q3 2020.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.3M shares
of 386M outstanding shares and own 1.63% of the company stock.
Largest 10 shareholders include HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.72M shares), RENAISSANCE TECHNOLOGIES LLC (1.68M shares), STONEHILL CAPITAL MANAGEMENT LLC (1.36M shares), ACADIAN ASSET MANAGEMENT LLC (515K shares), HEARTLAND ADVISORS INC (492K shares), MORGAN STANLEY (251K shares), CITADEL ADVISORS LLC (52.3K shares), SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (49.1K shares), HRT FINANCIAL LP (39.1K shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (28.1K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.